A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ticagrelor Impurity 166 - Request Quote

Picture of Ticagrelor Impurity 166

Ticagrelor Impurity 166

SZ CAT No:SZ-T023276
CAS No
NA
Mol.F.
C16H16F2N6S
Mol.Wt.
362.4
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ticagrelor Impurity 166 is chemically N-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine. Ticagrelor Impurity 166 is supplied with detailed characterization data compliant with regulatory guideline. Ticagrelor Impurity 166 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ticagrelor.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ticagrelor Impurity 166

Purchase Ticagrelor Impurity 166

Ticagrelor Impurity 166 suppliers

Ticagrelor Impurity 166 manufacturers

Ticagrelor Impurity 166 price

Order Ticagrelor Impurity 166

Enquire Ticagrelor Impurity 166

Ticagrelor Impurity 166 cost

Ticagrelor Impurity 166 Supplier

Ticagrelor Impurity 166 Distributor

Ticagrelor Impurity 166 for Method Validation

Ticagrelor Reference Standard

Ticagrelor Impurity 166 for ANDA Filing

Ticagrelor Impurity 166 for Forced Degradation Studies

Ticagrelor Impurity 166 Identification Standards

Ticagrelor Impurity 166 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,